Pfizer plans to charge nearly $1,400 for Paxlovid
![](https://media.kbin.social/media/ff/00/ff0049b189485032a88b06866bf44ba56169fc45a96e0d36a6a0e720b0ec8a99.jpg)
![](https://lemmy.world/pictrs/image/8f2046ae-5d2e-495f-b467-f7b14ccb4152.png)
axios.com
Pfizer will list its COVID-19 treatment Paxlovid at a price of $1,390 per five-day course when it soon hits the commercial market, the drugmaker confirmed to Axios.
Why it matters: Paxlovid's new listed price, first reported by the Wall Street Journal, will be more than twice the $529 paid by the federal government, which until now has maintained the entire U.S. supply of the key antiviral medication.
You are viewing a single comment
This is criminal.